Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing

Christine J. DiDonato, Christian L. Lorson, Yves De Repentigny, Louise Simard, Chantal Chartrand, Elliot Androphy, Rashmi Kothary

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Proximal spinal muscular atrophy (SMA) is caused by mutations in the survival motor neuron gene (SMN1). In humans, two nearly identical copies of SMN exist and differ only by a single non-polymorphic C→T nucleotide transition in exon 7. SMN1 contains a 'C' nucleotide at the +6 position of exon 7 and produces primarily full-length SMN transcripts, whereas SMN2 contains a 'T' nucleotide and produces high levels of a transcript that lacks exon 7 and a low level of full-length SMN transcripts. All SMA patients lack a functional SMN1 gene but retain at least one copy of SMN2, suggesting that the low level of full-length protein produced from SMN2 is sufficient for all cell types except motor neurons. The murine SMN gene is not duplicated or alternatively spliced. It resembles SMN1 in that the critical exon 7 +6 'C' nucleotide is conserved. We have generated Smn minigenes containing either wild-type Smn exon 7 or an altered exon 7 containing the C→T nucleotide transition to mimic SMN2. When expressed in cultured cells or transgenic mice, the wild-type minigene produced only full-length transcripts whereas the modified minigene alternatively spliced exon 7. Furthermore, Smn exon 7 contains a critical AG-rich exonic splice enhancer sequence (ESE) analogous to the human ESE within SMN exon 7, and subtle mutations within the mESE caused a variation in Smn transcript levels. In summary, we show for the first time that the murine Smn locus can be induced to alternatively splice exon 7. These results demonstrate that SMN protein levels can be varied in the mouse by the introduction of specific mutations at the endogenous Smn locus and thereby lay the foundation for developing animals that closely 'resemble' SMA patients.

Original languageEnglish (US)
Pages (from-to)2727-2736
Number of pages10
JournalHuman Molecular Genetics
Volume10
Issue number23
StatePublished - Nov 1 2001
Externally publishedYes

Fingerprint

Motor Neurons
Exons
Proteins
Nucleotides
Spinal Muscular Atrophy
Mutation
Genes
Transgenic Mice
Cultured Cells

ASJC Scopus subject areas

  • Genetics

Cite this

DiDonato, C. J., Lorson, C. L., De Repentigny, Y., Simard, L., Chartrand, C., Androphy, E., & Kothary, R. (2001). Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Human Molecular Genetics, 10(23), 2727-2736.

Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. / DiDonato, Christine J.; Lorson, Christian L.; De Repentigny, Yves; Simard, Louise; Chartrand, Chantal; Androphy, Elliot; Kothary, Rashmi.

In: Human Molecular Genetics, Vol. 10, No. 23, 01.11.2001, p. 2727-2736.

Research output: Contribution to journalArticle

DiDonato, CJ, Lorson, CL, De Repentigny, Y, Simard, L, Chartrand, C, Androphy, E & Kothary, R 2001, 'Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing', Human Molecular Genetics, vol. 10, no. 23, pp. 2727-2736.
DiDonato CJ, Lorson CL, De Repentigny Y, Simard L, Chartrand C, Androphy E et al. Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Human Molecular Genetics. 2001 Nov 1;10(23):2727-2736.
DiDonato, Christine J. ; Lorson, Christian L. ; De Repentigny, Yves ; Simard, Louise ; Chartrand, Chantal ; Androphy, Elliot ; Kothary, Rashmi. / Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. In: Human Molecular Genetics. 2001 ; Vol. 10, No. 23. pp. 2727-2736.
@article{52efd9ef111e4e86a300c64dbfcfe1da,
title = "Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing",
abstract = "Proximal spinal muscular atrophy (SMA) is caused by mutations in the survival motor neuron gene (SMN1). In humans, two nearly identical copies of SMN exist and differ only by a single non-polymorphic C→T nucleotide transition in exon 7. SMN1 contains a 'C' nucleotide at the +6 position of exon 7 and produces primarily full-length SMN transcripts, whereas SMN2 contains a 'T' nucleotide and produces high levels of a transcript that lacks exon 7 and a low level of full-length SMN transcripts. All SMA patients lack a functional SMN1 gene but retain at least one copy of SMN2, suggesting that the low level of full-length protein produced from SMN2 is sufficient for all cell types except motor neurons. The murine SMN gene is not duplicated or alternatively spliced. It resembles SMN1 in that the critical exon 7 +6 'C' nucleotide is conserved. We have generated Smn minigenes containing either wild-type Smn exon 7 or an altered exon 7 containing the C→T nucleotide transition to mimic SMN2. When expressed in cultured cells or transgenic mice, the wild-type minigene produced only full-length transcripts whereas the modified minigene alternatively spliced exon 7. Furthermore, Smn exon 7 contains a critical AG-rich exonic splice enhancer sequence (ESE) analogous to the human ESE within SMN exon 7, and subtle mutations within the mESE caused a variation in Smn transcript levels. In summary, we show for the first time that the murine Smn locus can be induced to alternatively splice exon 7. These results demonstrate that SMN protein levels can be varied in the mouse by the introduction of specific mutations at the endogenous Smn locus and thereby lay the foundation for developing animals that closely 'resemble' SMA patients.",
author = "DiDonato, {Christine J.} and Lorson, {Christian L.} and {De Repentigny}, Yves and Louise Simard and Chantal Chartrand and Elliot Androphy and Rashmi Kothary",
year = "2001",
month = "11",
day = "1",
language = "English (US)",
volume = "10",
pages = "2727--2736",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing

AU - DiDonato, Christine J.

AU - Lorson, Christian L.

AU - De Repentigny, Yves

AU - Simard, Louise

AU - Chartrand, Chantal

AU - Androphy, Elliot

AU - Kothary, Rashmi

PY - 2001/11/1

Y1 - 2001/11/1

N2 - Proximal spinal muscular atrophy (SMA) is caused by mutations in the survival motor neuron gene (SMN1). In humans, two nearly identical copies of SMN exist and differ only by a single non-polymorphic C→T nucleotide transition in exon 7. SMN1 contains a 'C' nucleotide at the +6 position of exon 7 and produces primarily full-length SMN transcripts, whereas SMN2 contains a 'T' nucleotide and produces high levels of a transcript that lacks exon 7 and a low level of full-length SMN transcripts. All SMA patients lack a functional SMN1 gene but retain at least one copy of SMN2, suggesting that the low level of full-length protein produced from SMN2 is sufficient for all cell types except motor neurons. The murine SMN gene is not duplicated or alternatively spliced. It resembles SMN1 in that the critical exon 7 +6 'C' nucleotide is conserved. We have generated Smn minigenes containing either wild-type Smn exon 7 or an altered exon 7 containing the C→T nucleotide transition to mimic SMN2. When expressed in cultured cells or transgenic mice, the wild-type minigene produced only full-length transcripts whereas the modified minigene alternatively spliced exon 7. Furthermore, Smn exon 7 contains a critical AG-rich exonic splice enhancer sequence (ESE) analogous to the human ESE within SMN exon 7, and subtle mutations within the mESE caused a variation in Smn transcript levels. In summary, we show for the first time that the murine Smn locus can be induced to alternatively splice exon 7. These results demonstrate that SMN protein levels can be varied in the mouse by the introduction of specific mutations at the endogenous Smn locus and thereby lay the foundation for developing animals that closely 'resemble' SMA patients.

AB - Proximal spinal muscular atrophy (SMA) is caused by mutations in the survival motor neuron gene (SMN1). In humans, two nearly identical copies of SMN exist and differ only by a single non-polymorphic C→T nucleotide transition in exon 7. SMN1 contains a 'C' nucleotide at the +6 position of exon 7 and produces primarily full-length SMN transcripts, whereas SMN2 contains a 'T' nucleotide and produces high levels of a transcript that lacks exon 7 and a low level of full-length SMN transcripts. All SMA patients lack a functional SMN1 gene but retain at least one copy of SMN2, suggesting that the low level of full-length protein produced from SMN2 is sufficient for all cell types except motor neurons. The murine SMN gene is not duplicated or alternatively spliced. It resembles SMN1 in that the critical exon 7 +6 'C' nucleotide is conserved. We have generated Smn minigenes containing either wild-type Smn exon 7 or an altered exon 7 containing the C→T nucleotide transition to mimic SMN2. When expressed in cultured cells or transgenic mice, the wild-type minigene produced only full-length transcripts whereas the modified minigene alternatively spliced exon 7. Furthermore, Smn exon 7 contains a critical AG-rich exonic splice enhancer sequence (ESE) analogous to the human ESE within SMN exon 7, and subtle mutations within the mESE caused a variation in Smn transcript levels. In summary, we show for the first time that the murine Smn locus can be induced to alternatively splice exon 7. These results demonstrate that SMN protein levels can be varied in the mouse by the introduction of specific mutations at the endogenous Smn locus and thereby lay the foundation for developing animals that closely 'resemble' SMA patients.

UR - http://www.scopus.com/inward/record.url?scp=0035510567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035510567&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 2727

EP - 2736

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 23

ER -